Astec LifeSciences Limited
Astec LifeSciences Limited (ASTEC) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
godrejastec.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 111 Cr | 51 Cr | 154 Cr | 69 Cr | 99 Cr | 94 Cr | 120 Cr | 91 Cr | 74 Cr | 125 Cr | 159 Cr | 84 Cr |
| Operating expenses (approx.) | 114 Cr | 69 Cr | 141 Cr | 116 Cr | 118 Cr | 100 Cr | 114 Cr | 102 Cr | 80 Cr | 121 Cr | 149 Cr | 84 Cr |
| EBITDA | -3 Cr | -18 Cr | 13 Cr | -46 Cr | -20 Cr | -6 Cr | 6 Cr | -11 Cr | -7 Cr | 4 Cr | 9 Cr | -0.67 Cr |
| OPM % | -3.1% | -36.1% | 8.3% | -66.7% | -20.0% | -6.1% | 4.6% | -12.1% | -9.1% | 3.2% | 5.8% | -0.8% |
| Other income | 0.98 Cr | 0.91 Cr | 2 Cr | 0.92 Cr | 2 Cr | 2 Cr | 0.79 Cr | 0.51 Cr | 1 Cr | 0.82 Cr | 3 Cr | 0.73 Cr |
| Interest | 6 Cr | 6 Cr | 7 Cr | 7 Cr | 9 Cr | 10 Cr | 10 Cr | 11 Cr | 8 Cr | 7 Cr | 8 Cr | 8 Cr |
| Depreciation | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 11 Cr | 11 Cr | 12 Cr | 11 Cr | 10 Cr | 11 Cr | 12 Cr | 11 Cr |
| Profit before tax | -18 Cr | -32 Cr | -0.93 Cr | -62 Cr | -39 Cr | -25 Cr | -16 Cr | -33 Cr | -24 Cr | -16 Cr | -8 Cr | -19 Cr |
| Tax % | 23.8% | 24.5% | -4.1% | 35.6% | -0.0% | -60.5% | -2.7% | -0.0% | -0.0% | -0.1% | 1.9% | 0.2% |
| Net profit | -13 Cr | -24 Cr | -0.96 Cr | -40 Cr | -39 Cr | -40 Cr | -16 Cr | -33 Cr | -24 Cr | -16 Cr | -8 Cr | -19 Cr |
| EPS (₹) | ₹-6.85 | ₹-12.41 | ₹0.50 | ₹-20.26 | ₹-19.66 | ₹-20.59 | ₹-8.20 | ₹-16.85 | ₹-11.35 | ₹-7.04 | ₹-3.48 | ₹-8.40 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 431 Cr | 523 Cr | 555 Cr | 677 Cr | 628 Cr | 458 Cr | 381 Cr | 448 Cr | Sign in for TTM |
| Operating expenses (approx.) | 354 Cr | 437 Cr | 443 Cr | 522 Cr | 552 Cr | 464 Cr | 448 Cr | 453 Cr | Sign in for TTM |
| EBITDA | 76 Cr | 85 Cr | 112 Cr | 154 Cr | 76 Cr | -6 Cr | -66 Cr | -5 Cr | Sign in for TTM |
| OPM % | 17.7% | 16.3% | 20.1% | 22.8% | 12.1% | -1.3% | -17.4% | -1.0% | Sign in for TTM |
| Other income | 11 Cr | 12 Cr | 8 Cr | 10 Cr | 13 Cr | 6 Cr | 6 Cr | 5 Cr | Sign in for TTM |
| Interest | 12 Cr | 13 Cr | 5 Cr | 9 Cr | 21 Cr | 25 Cr | 37 Cr | 35 Cr | Sign in for TTM |
| Depreciation | 19 Cr | 23 Cr | 26 Cr | 34 Cr | 34 Cr | 36 Cr | 44 Cr | 45 Cr | Sign in for TTM |
| Profit before tax | 56 Cr | 61 Cr | 89 Cr | 121 Cr | 35 Cr | -62 Cr | -141 Cr | -81 Cr | Sign in for TTM |
| Tax % | 36.0% | 22.5% | 26.9% | 25.8% | 26.8% | 24.1% | 4.5% | 0.2% | Sign in for TTM |
| Net profit | 36 Cr | 48 Cr | 65 Cr | 90 Cr | 26 Cr | -47 Cr | -135 Cr | -81 Cr | Sign in for TTM |
| EPS (₹) | ₹18.28 | ₹24.29 | ₹33.23 | ₹45.87 | ₹13.04 | ₹-23.93 | ₹-68.71 | ₹-37.79 | Sign in for TTM |
| Dividend payout % | — | — | — | 3.3% | 11.5% | — | — | — | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 20 Cr | 20 Cr | 20 Cr | 20 Cr | 20 Cr | 20 Cr | 20 Cr | 22 Cr |
| Reserves | 183 Cr | 227 Cr | 290 Cr | 377 Cr | 400 Cr | 350 Cr | 215 Cr | 368 Cr |
| Borrowings | 176 Cr | 99 Cr | 187 Cr | 279 Cr | 341 Cr | 494 Cr | 555 Cr | 449 Cr |
| Other liabilities | 83 Cr | 226 Cr | 181 Cr | 221 Cr | 219 Cr | 112 Cr | 92 Cr | 102 Cr |
| Total liabilities | 461 Cr | 572 Cr | 678 Cr | 897 Cr | 979 Cr | 975 Cr | 881 Cr | 942 Cr |
| Fixed assets (net) | 165 Cr | 192 Cr | 212 Cr | 338 Cr | 287 Cr | 353 Cr | 497 Cr | 424 Cr |
| CWIP | 19 Cr | 22 Cr | 112 Cr | 14 Cr | 112 Cr | 148 Cr | 0.13 Cr | 0.20 Cr |
| Investments | 0.0053 Cr | 0.0053 Cr | 0.0053 Cr | 0.0053 Cr | 30 Cr | 30 Cr | 0.0053 Cr | 30 Cr |
| Loans & advances | 0.05 Cr | 29 Cr | 0.08 Cr | 0.15 Cr | 0.02 Cr | 0.04 Cr | 3 Cr | 3 Cr |
| Inventories | 93 Cr | 121 Cr | 106 Cr | 187 Cr | 295 Cr | 196 Cr | 160 Cr | 138 Cr |
| Trade receivables | 122 Cr | 161 Cr | 187 Cr | 274 Cr | 155 Cr | 169 Cr | 147 Cr | 248 Cr |
| Cash & bank | 0.21 Cr | 0.31 Cr | 0.34 Cr | 0.55 Cr | 0.47 Cr | 0.47 Cr | 0.58 Cr | 10 Cr |
| Other assets | 63 Cr | 46 Cr | 61 Cr | 84 Cr | 100 Cr | 78 Cr | 74 Cr | 90 Cr |
| Total assets | 461 Cr | 572 Cr | 678 Cr | 897 Cr | 979 Cr | 975 Cr | 881 Cr | 942 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 24 Cr | 75 Cr | 10 Cr | -8 Cr | -81 Cr |
| Cash from investing | — | — | — | -104 Cr | -113 Cr | -135 Cr | -15 Cr | -4 Cr |
| Cash from financing | — | — | — | 80 Cr | 38 Cr | 125 Cr | 24 Cr | 94 Cr |
| Net cash flow | — | — | — | 0.22 Cr | -0.08 Cr | -0.0019 Cr | 0.10 Cr | 9 Cr |
| Free cash flow (OCF − Capex) | — | — | — | -80 Cr | -43 Cr | -125 Cr | -30 Cr | -86 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 33.7% | 30.0% | 30.3% | 32.8% | 7.3% | -4.2% | -13.2% | -5.5% |
| ROE % | 17.6% | 19.3% | 21.0% | 22.7% | 6.1% | -12.7% | -57.3% | -20.7% |
| Debtor days | 103 | 112 | 123 | 147 | 90 | 135 | 141 | 201 |
| Inventory days | 115 | 133 | 112 | 153 | 233 | 224 | 234 | 186 |
| Days payable | 78 | 222 | 132 | 155 | 140 | 102 | 119 | 118 |
| Cash conversion cycle | 139 | 23 | 103 | 145 | 183 | 257 | 255 | 269 |
| Debt / equity | 0.87 | 0.40 | 0.60 | 0.01 | 0.81 | 1.34 | 2.36 | 1.15 |
| Current ratio | 1.01 | 1.05 | 1.03 | 1.05 | 0.95 | 1.00 | 0.93 | 0.89 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 4.47 | — | — | — |
Compare with peers
Loading peers…